Hong Kong Personal Products Stock News

Why the Crescent Biopharma partnership matters for Sichuan Kelun-Biotech Biopharmaceutical The new collaboration between Crescent Biopharma and Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) on next generation oncology drugs, including joint clinical trials, is drawing fresh attention from investors to Kelun-Biotech's pipeline and funding position. See our latest analysis for Sichuan Kelun-Biotech Biopharmaceutical. At the latest share price of HK$387.4, Sichuan Kelun-Biotech...

MiniMax Group stock moves after sharp month-long rally MiniMax Group (SEHK:100) has drawn fresh attention after a sharp move in its share price over the past month, prompting investors to reassess the newly listed AI foundation model developer. See our latest analysis for MiniMax Group. The latest pullback, including a 3.17% 1 day share price return decline and 21.29% 7 day share price return decline, comes after a 56.45% 30 day and 121.30% year to date share price return. This suggests...

Recent share move and business snapshot Ascentage Pharma Group International (SEHK:6855) has seen its share price move recently, with a 1 day return of about 1.4% and a decline of roughly 26.9% over the past 3 months, drawing attention to its clinical stage biotech profile. See our latest analysis for Ascentage Pharma Group International. Looking beyond the latest move, the share price has recorded a 4.9% decline over the past month and a 26.9% decline over the past quarter, while the 1 year...

China Qinfa Group (SEHK:866) has issued new earnings guidance, telling investors to expect a loss after taxation of not more than CN¥98,000,000 for 2025, compared with a profit of about CN¥556,370,000 in 2024. See our latest analysis for China Qinfa Group. The earnings guidance sits against a very strong recent run in the stock, with a 1-day share price return of 8.09% and a year to date share price return of 41.67%. The 1-year total shareholder return is very large and multi year total...

CSPC Pharmaceutical Group (SEHK:1093) has received regulatory clearance for two long-acting drug candidates, including a monthly GLP-1/GIP injection in the US and a week-long ropivacaine pain therapy trial in China. See our latest analysis for CSPC Pharmaceutical Group. These trial approvals arrive after a strong 116.18% 1-year total shareholder return and a 25.16% 90-day share price return, although the 30-day share price return of 6.16% and recent 7-day weakness suggest shorter term...

JPMorgan’s upgrade of Cathay Pacific Airways (SEHK:293), which followed the expiry of its buyback plan on 24 February 2026, has put fresh attention on the airline’s balance sheet, cash generation, and sizeable aircraft commitments. See our latest analysis for Cathay Pacific Airways. At a share price of HK$14.06, Cathay Pacific’s recent 7 day share price return of 10.53% and 90 day share price return of 16.58% sit alongside a 1 year total shareholder return of 46.56%. This suggests momentum...

CALB Group (SEHK:3931) has issued a profit alert indicating an expected 140% to 160% increase in its 2025 net profit, citing stronger sales of advanced batteries for passenger vehicles, commercial applications, and energy storage systems. See our latest analysis for CALB Group. The profit alert lands after a mixed period for the stock, with a 30 day share price return of 4.51% and a 90 day share price decline of 8.53%, while the 1 year total shareholder return of 59.66% points to stronger...

Grand Pharmaceutical Group (SEHK:512) has drawn investor attention after posting annual revenue of HK$11,704.979 million and net income of HK$2,079.449 million, putting fresh focus on how its diversified healthcare business is currently valued. See our latest analysis for Grand Pharmaceutical Group. At a share price of HK$7.83, Grand Pharmaceutical Group has seen short term share price pressure, with a 90 day share price return decline of 4.74%. However, its 1 year total shareholder return of...

Full year 2025 results and what changed Xinyi Solar Holdings (SEHK:968) has released full year 2025 results showing sales of CNY 20,861.16 million and net income of CNY 844.53 million, both lower than the previous year. This is likely shaping current investor sentiment. See our latest analysis for Xinyi Solar Holdings. The share price has reacted to the weaker full year 2025 results, but still shows a 13.07% year to date share price return and a 7.45% 90 day share price return. However, the 3...

Earlier this week, Lenovo announced Premier Support Plus for Servers, its highest-tier, AI-driven enterprise support for ThinkSystem and ThinkAgile servers, and expanded its ThinkEdge portfolio with new rugged, AI-ready edge computing devices, including the SE10n Gen 2, SE30n Gen 2, SE60n Gen 2, and the SE50a Panel PC. Taken together, these launches highlight Lenovo’s push to pair AI-enabled infrastructure with premium, proactive support services aimed at always-on, mission-critical...

Shougang Fushan Resources Group (SEHK:639) issued earnings guidance for 2025 that points to a sharp profit drop, as weaker clean coking coal prices and a shift in product mix weigh on expected results. See our latest analysis for Shougang Fushan Resources Group. The earnings guidance arrives after a strong run in the shares, with the HK$3.37 latest price coming alongside a 90 day share price return of 15.81% and a one year total shareholder return of 57.98%. This suggests recent momentum has...

On 23 February 2026, Fosun International received the "Certificate of Excellence in Environmental, Social and Governance Reporting" from the Hong Kong Management Association, recognizing its ESG reporting quality and climate-related disclosure efforts. This award underlines how Fosun’s “Create IMPACT” sustainable development strategy has embedded transparency, climate action, and governance into its core business approach. We’ll now examine how Fosun’s strengthened ESG reporting and climate...

Galaxy Entertainment Group (SEHK:27) opened FY 2025 with first half revenue of HK$23.2b and basic EPS of HK$1.20, supported by trailing 12 month revenue of HK$50.7b and EPS of HK$2.44 that reflects earnings growth of 21.9% year over year. Over recent periods the company has seen revenue move from HK$21.5b in 1H 2024 to HK$22.0b in 2H 2024 and then to HK$23.2b in 1H 2025, alongside EPS ranging from HK$1.00 to HK$1.20 per half. This sets up a results season where stronger earnings and a 21.1%...

Hong Kong Exchanges and Clearing (SEHK:388) has wrapped up FY 2025 with fourth quarter revenue of HK$7.5b and basic EPS of HK$3.43, capping a year in which trailing twelve month revenue reached HK$29.2b and EPS came in at HK$14.05. The company has seen revenue move from HK$20.7b and EPS of HK$9.38 in the trailing twelve months to Q3 2024 to HK$29.2b and EPS of HK$14.05 in the trailing twelve months to Q4 2025. Net income tracked from HK$11.9b to HK$17.8b over the same span, leaving investors...

CTF Services (SEHK:659) has opened H1 2026 with revenue of HK$12.2b and basic EPS of HK$0.23, against a backdrop where trailing 12 month figures point to HK$25.0b in revenue and EPS of HK$0.53. Over recent half year periods the company has seen revenue move from HK$12.4b in H2 2024 to HK$12.1b in H1 2025 and HK$12.2b in H2 2025, while EPS has shifted from HK$0.25 to HK$0.26 and then HK$0.23, placing this latest result within a steady earnings season narrative. With trailing net margins framed...

Hysan Development (SEHK:14) has put fresh numbers on the table for FY 2025, with first half revenue at HK$1,838 million and basic EPS of HK$0.07. This sets the tone after a mixed FY 2024 that saw revenue move from HK$1,613 million to HK$1,713 million, while EPS shifted between HK$0.42 and a loss of HK$0.38. Over the trailing 12 months, revenue ranged between HK$3,326 million and HK$3,551 million, with EPS moving from HK$0.03 to HK$0.31. This gives investors a broader view of how earnings...

Sun Hung Kai Properties (SEHK:16) posts H1 2026 results Sun Hung Kai Properties (SEHK:16) has put fresh numbers on the board for H1 2026, with revenue of HK$39.8 billion and basic EPS of HK$4.06, backed by trailing twelve month revenue of HK$92.5 billion and EPS of HK$7.59. The company has seen revenue shift from HK$43.96 billion and EPS of HK$3.42 in H2 2024 to HK$39.93 billion and HK$2.60 in H1 2025, before landing at HK$39.79 billion and HK$4.06 in the latest half. This sets up a results...

CLP Holdings (SEHK:2) has just posted its FY 2025 first half numbers, with revenue of HK$42.9b and basic EPS of HK$2.23, setting the tone for how its earnings story is evolving. The company has seen revenue move from HK$44.1b in 1H 2024 to HK$46.9b in 2H 2024 and HK$42.9b in 1H 2025, while EPS has gone from HK$2.36 to HK$2.29 and then HK$2.23 over the same periods. This puts the focus squarely on how margins are holding up through the latest results. See our full analysis for CLP...

If you are wondering whether Geely Automobile Holdings is attractively priced or not, this article will walk you through what the current share price might be implying about its value. The stock last closed at HK$16.31, with a 7 day return of 4.3% decline, a 30 day return of 1.3% decline, a year to date return of 10.4% decline, a 1 year return of 12.4% decline and a 3 year return of 66.1% alongside a 5 year return of 27.7% decline. This gives a mixed picture for investors weighing recent...

Why Time Interconnect Technology’s Equity Offering Matters Now Time Interconnect Technology (SEHK:1729) has just completed a HK$1.64b follow on equity offering, issuing 108,000,000 new ordinary shares at HK$15.22 in a subsequent direct listing. The company plans to use the funds for investments, acquisitions, global business development, and general corporate purposes, while also increasing its public float. This combination can reshape how investors think about its growth plans and...

Board meeting puts earnings and dividend plans in focus Impro Precision Industries (SEHK:1286) has set 10 March 2026 for a board meeting to approve its 2025 annual results and consider a second interim dividend. This combination directly matters for shareholder income and valuation. See our latest analysis for Impro Precision Industries. Impro Precision’s share price has moved to HK$8.06, with a 30 day share price return of 26.33% and a 90 day gain of 48.16%, while the 1 year total...

Latest Earnings Snapshot Nine Dragons Paper (Holdings) (SEHK:2689) has reported H1 2026 results that keep the recent turnaround in focus, with trailing twelve month revenue at C¥66.997b and basic EPS at C¥0.83 alongside a 252% year-on-year rise in reported earnings and a net profit margin of 4.9% versus 1.5% a year earlier. The company has seen half year revenue move from C¥28.885b in H2 2024 to C¥29.776b in H2 2025. Basic EPS went from C¥0.10 in H1 2025 to C¥0.28 in H2 2025, setting up a...

Why CK Hutchison Holdings Is On Investors’ Radar CK Hutchison Holdings (SEHK:1) has caught investor attention after a strong past 3 months, with a return of about 18%, which is prompting a closer look at how its diversified operations and earnings profile compare. See our latest analysis for CK Hutchison Holdings. At a current share price of HK$64.8, CK Hutchison’s recent 4.52% 1 day share price return and 17.93% 90 day share price return sit alongside a 71.89% 1 year total shareholder...

What Meituan’s 2025 Loss Guidance Means for Investors Meituan (SEHK:3690) has issued earnings guidance for 2025, flagging an expected loss of about CN¥23.3b to CN¥24.3b, compared with a profit of roughly CN¥35.8b in 2024. The company links this swing to an anticipated operating loss of around CN¥6.8b to CN¥7b in its Core Local Commerce segment and to higher spending on overseas expansion, which it frames as a response to intense industry competition. See our latest analysis for...